Genomic Panel Testing – Potential Treatments

Targeted Therapies

• Afatinib (Gilotrif, Boehringer Ingelheim)
• Erlotinib (Tarceva; Genentech, Astellas)
• Gefitinib (Iressa, AstraZeneca)

Immunotherapies

• Atezolizumab (Tecentriq, Genentech)
• Nivolumab (Opdivo, Bristol-Myers Squibb)
• Pembrolizumab (Keytruda, Merck)

Genomic Panel Testing – Tumor Mutational Load

Genomic Panel Testing – PD-L1 Tumor Proportion Score